Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Kirsten Trayner

Biographic Data

ID7446741
NAMEKirsten Trayner
GIVEN NAMESKirsten
FAMILY NAMETrayner
SIGNATURETRAYNER K
AFFILIATIONSGlasgow Caledonian University
VERIFIEDNo
TOTAL WORKS3
TOTAL CITATIONS0
AUTHOR COUNT3
EDITOR COUNT0
FIRST PUBLICATION YEAR2022
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Drug-related death rates associated with prescribed and illicit benzodiazepine exposure among people receiving opioid-agonist treatment in Scotland, 2015 to 2020

    Open Access•Megan Glancy, Norah Palmateer et al.•ARTICLE•International Journal of Drug…•2026

    BACKGROUND: Opioid agonist treatment (OAT) reduces mortality among individuals with opioid dependence. Benzodiazepine co-prescribing with OAT has previously been associated with increased rates of drug-related death (DRD). In Scotland, rising DRD rates have coincided with increasing detection of illicit benzodiazepines at post-mortem. We quantified DRD rates associated with prescribed and baseline self-reported illicit benzodiazepine exposure amo…

  • Risk of drug-related mortality among people receiving opioid-agonist treatment during the Covid-19 pandemic in Scotland

    Open Access•Megan Glancy, Andrew Mcauley et al.•ARTICLE•International Journal of Drug…•2025

    During the COVID-19 pandemic in Scotland, DRD rates remained stable following a three-fold rise since 2011-13. The protective effect of OAT was sustained during the pandemic, which highlights the importance of maintaining access to OAT during public health crises

  • Interventions to prevent HIV and Hepatitis C among people who inject drugs

    Open Access•Norah E Palmateer, Victoria Hamill et al.•ARTICLE•International Journal of Drug…•2022

No prominent works on this page.

  • Interventions to prevent HIV and Hepatitis C among people who inject drugs

    Open Access•Norah E Palmateer, Victoria Hamill et al.•ARTICLE•International Journal of Drug…•2022

  • Risk of drug-related mortality among people receiving opioid-agonist treatment during the Covid-19 pandemic in Scotland

    Open Access•Megan Glancy, Andrew Mcauley et al.•ARTICLE•International Journal of Drug…•2025

    During the COVID-19 pandemic in Scotland, DRD rates remained stable following a three-fold rise since 2011-13. The protective effect of OAT was sustained during the pandemic, which highlights the importance of maintaining access to OAT during public health crises

  • Drug-related death rates associated with prescribed and illicit benzodiazepine exposure among people receiving opioid-agonist treatment in Scotland, 2015 to 2020

    Open Access•Megan Glancy, Norah Palmateer et al.•ARTICLE•International Journal of Drug…•2026

    BACKGROUND: Opioid agonist treatment (OAT) reduces mortality among individuals with opioid dependence. Benzodiazepine co-prescribing with OAT has previously been associated with increased rates of drug-related death (DRD). In Scotland, rising DRD rates have coincided with increasing detection of illicit benzodiazepines at post-mortem. We quantified DRD rates associated with prescribed and baseline self-reported illicit benzodiazepine exposure amo…

Opioid Use Disorder Treatment (2 works) · 2019-20 coronavirus outbreak (1 works) · Agonist (1 works) · Benzodiazepine (1 works) · Buprenorphine (1 works) · Cardiac Arrest and Resuscitation (1 works) · Coronavirus disease 2019 (COVID-19 (1 works) · Drug (1 works) · Emergency Medicine (1 works) · Forensic Toxicology and Drug Analysis (1 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae